Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NuCana plc
Institut Bergonié
UNC Lineberger Comprehensive Cancer Center
NRG Oncology
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
NSABP Foundation Inc
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
SCRI Development Innovations, LLC
University of Louisville
Fox Chase Cancer Center
Brown University
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
AbbVie
Amgen
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
City of Hope Medical Center
Georgetown University
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Eli Lilly and Company